Citations

Clear

38 citation(s) found for "Smith, Ryan".

Equivalent Cellular and Humoral Immunity to Varicella Zoster Virus in Patients With Inflammatory Bowel Disease and Healthy Older Adults for Whom Immunization Is Recommended
Caldera, Freddy , Wald, Arnold , Saha, Sumona , McCrone, Sue, Caldera, Freddy , Smith, Ryan C. , Farraye, Francis A. , Hayney, Mary S.

Mayo Clinic

Clinical and Translational Gastroenterology | January 21, 2022 | Volume: 13 | Issue: 1 | Pages: e00446

10.14309/ctg.0000000000000446 | PMID 35060934 Get It

INTRODUCTION: Patients with inflammatory bowel disease (IBD) are at an increased risk of herpes zoster (HZ). HZ is caused by reactivation of the varicella zoster virus (VZV) and is prevented by strong VZV-specific cell-mediated immunity. The aim of our study was to evaluate whether patients with IBD had lower or equivalent protection compared with healthy controls (HCs) at age 50 years and older. METHODS: We performed a cross-sectional study at a single academic center and evaluated cellular and humoral immunity to VZV in patients with IBD at age 35–49 years vs HCs aged 50–59 years. All patients with IBD were on stable medication regimens for at least 3 months. VZV-specific cell-mediated immunity was measured via ELISPOT, and humoral immunity was measured via a quantitative VZV antibody enzyme-linked immunosorbent assay assay. RESULTS: Seventy-seven patients with IBD and 12 HCs were enrolled in the study. There was no significant difference in ELISPOT counts between patients with IBD and HCs ( P = 0.54). In addition, there was also no significant difference between ELISPOT counts in immunosuppressed patients with IBD (N = 45) and HCs ( P = 0.32). We also found no correlations between ELISPOT counts and age (Spearman rho 0.014; P = 0.90). Patients with IBD had similar IgG VZV antibody levels (median 19 mIU/mL; range 0.5–218) compared with HCs (median 23.5 mIU/mL (range 4–34); P = 0.54). DISCUSSION: Young patients with IBD have equivalent cellular and humoral immunity to VZV as healthy older adults in whom HZ immunization is recommended.
Common questions and misconceptions about creatine supplementation: what does the scientific evidence really show?
Candow, Darren G. , Kreider, Richard B. , Rawson, Eric S., VanDusseldorp, Trisha A. , Willoughby, Darryn S. , Ziegenfuss, Tim N. , Antonio, Jose , Kreider, Richard B , António, José , Forbes, Scott C. , Gualano, Bruno , Jagim, Andrew R. , Smith‐Ryan, Abbie E.

Mayo Clinic

Journal of the International Society of Sports Nutrition | February 8, 2021 | Volume: 18 | Issue: 1 | Pages: No page available

10.1186/s12970-021-00412-w | PMID 33557850 Get It

A scalable workflow for the human exposome
Hu, Xin , Liang, YongLiang, Juran, Brian D., Ma, Chunyu , Martin, Greg S. , Neujahr, David C., Lazaridis, N., Martin, Greg S , Walker, Douglas Ian , Liang, YongLiang, Smith, Matthew Ryan , Orr, Michael C. , Uppal, Karan , Marsit, Carmen J. , Go, Young‐Mi , Pennell, Kurt D. , Miller, Gary W. , Jones, Dean P.

Mayo Clinic

No container title available | October 9, 2020 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-83843/v1 Get It

Abstract Complementing the genome with an understanding of the human exposome is an important challenge for contemporary science and technology. Tens of thousands of chemicals are used in commerce, yet cost for targeted environmental chemical analysis limits surveillance to a few hundred known hazards. To overcome limitations which prevent scaling to thousands of chemicals, we developed a single-step express liquid extraction (XLE), gas chromatography high-resolution mass spectrometry (GC-HRMS) analysis and computational pipeline to operationalize the human exposome. We show that the workflow supports quantification of environmental chemicals in small human plasma (200 µL) and tissue (≤ 100 mg) samples. The method also provides high resolution, sensitivity and selectivity for exposome epidemiology of mass spectral features without a priori knowledge of chemical identity. The simplicity of the method can facilitate harmonization of environmental biomonitoring between laboratories and enable population level human exposome research with limited sample volume.
Pulmonary Manifestations in a Patient with Chai Disease
Smith, Ryan J. , Mertz, L. E., Teaford, Harry G., Cartin‐Ceba, Rodrigo

Mayo Clinic

A34. AUTO IMMUNE LUNG DISEASE: CASE REPORTS | July 7, 2020 | Volume: No volume available | Issue: No issue available | Pages: A1382-A1382

10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a1382 Get It

Peripherally inserted central catheter placement in a multidisciplinary intensive care unit: A preliminary study demonstrating safety and procedural time in critically ill subjects
Smith, Ryan J. , Cartin‐Ceba, Rodrigo , Colquist, Julie , Muir, Amy M, Moorhead, Jeanine M, Callisen, Hannelisa, Patel, B. M. , Colquist, Julie A, Callisen, Hannelisa E, Patel, Bhavesh M

Mayo Clinic

The Journal of Vascular Access | June 9, 2020 | Volume: 22 | Issue: 1 | Pages: 101-106

10.1177/1129729820928618 | PMID 32515261 Get It

Objective: Peripherally inserted central catheters are a popular means of obtaining central venous access in critically ill patients. However, there is limited data regarding the rapidity of the peripherally inserted central catheter procedure in the presence of acute illness or obesity, both of which may impede central venous catheter placement. We aimed to determine the feasibility, safety, and duration of peripherally inserted central catheter placement in critically ill patients, including obese patients and patients in shock. Methods: This retrospective cohort study was performed using data on 55 peripherally inserted central catheters placed in a 30-bed multidisciplinary intensive care unit in Mayo Clinic Hospital, Phoenix, Arizona. Information on the time required to complete each step of the peripherally inserted central catheter procedure, associated complications, and patient characteristics was obtained from a prospectively assembled internal quality assurance database created through random convenience sampling. Results: The Median Procedure Time, beginning with the first needle puncture and ending when the procedure is complete, was 14 (interquartile range: 9–20) min. Neither critical illness nor obesity resulted in a statistically significant increase in the time required to complete the peripherally inserted central catheter procedure. Three (5.5%) minor complications were observed. Conclusion: Critical illness and obesity do not delay the acquisition of vascular access when placing a peripherally inserted central catheter. Concerns of delayed vascular access in critically ill patients should not deter a physician from selecting a peripherally inserted central catheter to provide vascular access when it would otherwise be appropriate.
Chronic CSF leak causing syringomyelia and pseudo-Arnold-Chiari malformation
Smith, Ryan M. , Garza, Ivan , Robertson, Carrie E. , Robertson, Carrie E

Mayo Clinic

Neurology | December 1, 2015 | Volume: 85 | Issue: 22 | Pages: 1994-1994

10.1212/wnl.0000000000002178 | PMID 26628487 Get It

Orthostatic headache from supratentorial meningioma
Smith, Ryan M. , Robertson, Carrie E. , Garza, Ivan , Robertson, Carrie E

Mayo Clinic

Cephalalgia | February 9, 2015 | Volume: 35 | Issue: 13 | Pages: 1214-1214

10.1177/0333102415570763 | PMID 25667301 Get It

Severe Respiratory Distress
Naim, Maryam Y. , Schears, Gregory J. , Smith, Ryan J.

Mayo Clinic

Clinical Pediatrics | March 31, 2006 | Volume: 43 | Issue: 4 | Pages: 403-405

10.1177/000992280404300416 | PMID 15118788 Get It